Genelux (GNLX) Capital Expenditures (2022 - 2026)
Genelux's Capital Expenditures came in at $921,000 for Q1 2026, compared with $30,000 a year earlier and up 111.2% from the prior quarter.
Powered by 
Analysis
Genelux (GNLX) Capital Expenditures (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Genelux reported Capital Expenditures of $1.99 million, up 422.0% year-over-year; for FY2025, it came in at $1.1 million, up 188.2% from FY2024.
- Capital Expenditures carries a three-year compound annual growth rate of 181.9% (FY2022 to FY2025).
- Going back by year, Capital Expenditures was $381,000 in FY2024 (-62.8%), $1.03 million in FY2023 and $49,000 in FY2022.
- The Q1 2026 figure represents the highest quarterly Capital Expenditures in data going back to Q1 2022.
- Year-over-year, Capital Expenditures increased in 1 of the last six quarters, with growth averaging 18.6%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2023 (growth of 626.7%), and the weakest in Q3 2024 (a decline of 90.3%).
- Business Quant data shows GNLX's Capital Expenditures at $436,000 (Q4 2025), $517,000 (Q3 2025) and $115,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Genelux | 91.17 Mn | 29.45 Mn | - | 921,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 921,000.00 |
| Dec 31, 2025 | 436,000.00 |
| Sep 30, 2025 | 517,000.00 |
| Jun 30, 2025 | 115,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 228,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 243,000.00 |
| Sep 30, 2023 | 277,000.00 |
| Jun 30, 2023 | 396,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Mar 31, 2022 | 15,000.00 |
API Access
Genelux Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();